Example: Heart Attack

Search clinical trials for: Plasminogen

Total 318 results

NCT02690714

Completed

A Study of Prometic Plasminogen IV Infusion in Subjects With Hypoplasminogenemia

Conditions: Hypoplasminogenemia
NCT01554956

Completed

Efficacy/Safety of Human Plasminogen Eye Drop in Ligneous Conjunctivitis Patients

Conditions: Ligneous Conjunctivitis
NCT02312180

Completed

A Phase 1 Study of ProMetic Plasminogen (Human) Intravenous in Adults and Children With Plasminogen Deficiency

Conditions: Type I Plasminogen Deficiency; Hypoplasminogenemia
NCT03851965

Completed

Assessment of the Soluble Urokinase Plasminogen Activator Receptor in Non-cardiac Surgery (SPARSE)

Conditions: Surgery--Complications
NCT04110275

Not yet recruiting

Injection of Recombinant Human Tissue-type Plasminogen Activator Derivative for Acute Pulmonary Embolism(rPA)

Conditions: Acute Pulmonary Embolism
NCT04170647

Recruiting

Efficacy of Intravenous Tissue-type Plasminogen Activator on Acute Ischemic Stroke Patients With Large Vessel Occlusions

Conditions: Stroke, Ischemic; Stroke, Acute
NCT01194674

Terminated

Microplasmin Intravitreal Administration in Participants With Uveitic Macular Edema

Conditions: Uveitis
NCT03265171

No longer available

A Single-patient Study of Repeat-dose Administration of Prometic Plasminogen (Human) Intravenous

Conditions: Hypoplasminogenemia
NCT04588220

Active, not recruiting

Melatonin, Soluble Urokinase-type Plasminogen Activator Receptor, and Orosomucoid 2 Levels in PPROM

Conditions: Preterm Premature Rupture of Membranes
NCT00996684

Unknown status

Study of Intravitreal Microplasmin in Relieving Vitreo-Macular Adhesion in Neovascular Age-related Macular Degeneration

Conditions: Macular Degeneration
NCT04453371

Not yet recruiting

Impact of Tissue Plasminogen Activator (tPA) Treatment for an Atypical Acute Respiratory Distress Syndrome (COVID-19)

Conditions: Acute Respiratory Distress Syndrome
NCT00418275

Completed

Safety Study of a Recombinant Human Plasminogen Activator to Treat Acute Ischemic Stroke.

Conditions: Cerebrovascular Accident
NCT04634799

Recruiting

Study To antagOnize Plasminogen Activator Inhibitor-1 in Severe COVID-19

Conditions: Covid19
NCT04275232

Enrolling by invitation

Allogenic Plasma Aliquots in the Treatment of Ligneous Conjunctivitis

Conditions: Ligneous Conjunctivitis, Left Eye
NCT04356833

Recruiting

Nebulised Rt-PA for ARDS Due to COVID-19

Conditions: COVID
NCT01055535

Completed

Safety and Efficacy Study of Microplasmin in for Non-Surgical Treatment of Focal Vitreomacular Adhesion

Conditions: Focal Vitreomacular Adhesion
NCT01098890

Unknown status

Intraventricular Tissue Plasminogen Activator (tPA) in the Management of Aneurysmal Subarachnoid Hemorrhage

Conditions: Aneurysmal Subarachnoid Hemorrhage; Intraventricular Hemorrhage
NCT04586062

Available

Sponsor Initiated Expanded Access Protocol, Intermediate-Size Patient Population

Conditions: Ligneous Conjunctivitis
NCT03966079

Completed

Thrombolysis Endovascular Treatment of Pulmonary Embolism

Conditions: Pulmonary Embolism; Acute Pulmonary Embolism
NCT04028518

Not yet recruiting

A PhaseⅡ of Injection for Recombinant Human Tissue Plasminogen Kinase Derivative in Treatment of Acute Ischemic Stroke.

Conditions: Acute Ischemic Stroke
NCT04590794

Active, not recruiting

SuPAR in Adult Patients With Covid-19

Conditions: Covid19
NCT02752256

Completed

Thrombolytic Care During Inter-hospital Transfer

Conditions: Stroke
NCT03335839

Recruiting

Adjunctive, Low-dose tPA in Primary PCI for STEMI

Conditions: Myocardial Infarction; Percutaneous Coronary Intervention
NCT01141881

Terminated

Evaluation of the Role of Intravitreal Tissue Plasminogen Activator in Treatment of Refractory Diabetic Macular Edema

Conditions: Diabetic Macular Edema
NCT01717742

Completed

Intrapleural DNase and Tissue Plasminogen Activator in Pediatric Empyema (DTPA Trial)

Conditions: Pleural Empyema